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ABSTRACT
In our previous studies, ingestion of prebiotics in low fat diets resulted in decreased cecal
pH from 8 to about 6 and increases in short chain fatty acids indicating robust fermentation.
However, in some preliminary studies this effect on fermentation was not seen when rodents
were obese and/or fed a high-fat diet. This comprehensive high-fat diet study was conducted to
determine which sources and combinations of prebiotics would enhance fermentation despite a
high dietary fat content. The effects of prebiotics in a high-fat diet (44% energy) on pH, cecal
weights, abdominal fat, and body weight were studied in mature male C57Bl/6 mice fed one of 9
diets of similar energy (4.0 ± 0.2 kcal/g) for 12 weeks. A control (C) diet was compared to 4
prebiotics: Hi-Maize® RS2 (R), Novelose® RS3 (N), Nutraflora® fructooligosaccharide (F),
BENEO-Orafti HP gel® inulin (I), which were fed individually and combined (F+I, R+F, R+I,
and R+N). Results were significant at p<0.05. Fermentation, indicated by lower pH values,
occurred with all F and I diets and combination diets. However, none of the groups had reduced
abdominal fat compared to control as has been observed in previous studies with consumption of
RS in low fat diets. All prebiotic diets had larger empty ceca, but only F and I had greater full
ceca than the RS groups. It is proposed that diets with high concentrations of fat affect
monogastric fermentation and microbial populations in a manner similar to ruminants. It is
possible that the beneficial health effects of prebiotic ingestion may be most effective if
consumed with a low-fat diet.
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CHAPTER 1: INTRODUCTION
Significance of Research
The number of individuals in the United States that are overweight and obese, which is
defined as a BMI of 25-29.9 or ≥30, respectively, has risen dramatically over the past 35 years.
According to Flegal et al (2010), in 2007-2008, the age-adjusted prevalence of obesity was
32.2% for men and 35.5% for women. The corresponding prevalence for overweight and obesity
combined was estimated to be 72.3% for men and 64.1% for women. Obesity is associated with
increased morbidity and mortality since it is a risk factor for many life-threatening, nutritionrelated diseases and conditions such as: cardiovascular disease (Willett et al, 1995; Manson et al,
1990), hypertension (Montani et al, 2002), diabetes (Mokdad et al, 2004), and a variety of
cancers (Calle and Thun, 2004). Therefore, finding effective means of preventing and treating
overweight and obesity is of great importance to public health.
Dietary intervention has its limitations as most people are incapable of making the
deliberate, lifelong dietary changes necessary for sustainable weight loss (Friedman, 2004). This
is why attention should be paid to the development of new food additives and/or food products
that improve the health of the consumer, and helps them to make positive lifestyle changes that
do not require significant mental effort. Fiber has the potential to fill this role since its
consumption is correlated with reduced food intake and improved weight status, ostensibly by
promoting satiety by slowing gastric emptying (Heaton, 1973); by diluting the energy of the diet
in which it is found (Rolls, 2000; Kim and Popkin, 2006); by stimulating the production of
satiating gut hormones (Slavin, 2005); and by decreasing the absorption of fatty acids in the
small intestine (Gades and Stern, 2003). In fact, populations that report higher fiber consumption
also exhibit lower rates of obesity in both adults and children (Kimm, 1995). A handful of cross-
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sectional, observational studies reveal inverse associations between fiber and body weight
(Alfieri et al, 1995; Appleby et al, 1998) and between fiber and body fat (Nelson and Tucker,
1996). Optimally, people should increase the fiber content of their diet by increasing the
consumption of fruits and vegetables, because these whole foods contain other compounds, such
as phytochemicals, which are beneficial to human health and would be absent from purified
fibers. However, some fiber is better than no fiber at all. Fiber can be added to preexisting
foodstuffs with relative ease, which can be accomplished by the food industry, thereby
eliminating the need for consumers to exert unnecessary effort to include it in his or her diet.
There are many different types of fiber. Resistant starches (RS) belong to a group of
nondigestible fibers that resist, by varying degrees, digestion in the small intestine. By definition
of being a starch, glucose molecules in the chains of RS are bonded together by α-bonds and are
digestible by α-amylase. However, RS is usually not digested because of the matrix (RS1),
granular structure (RS2 and RS3), or the addition of novel chemical bonds (RS4). Thus, they
have a reduced caloric value compared to most starches. RS is fermented, or metabolized, for
energy and growth by the resident microflora of the large intestine, resulting in increased
bacterial biomass. Other byproducts of this reaction are short chain fatty acids (SCFAs), mainly
acetate, propionate, and butyrate (Topping and Clifton, 2001). These products reduce the pH of
the gut, prevent the proliferation of harmful, pathogenic bacteria, and are a major source of
energy for colonocytes, thereby contributing to overall gut health (Xu and Gordon, 2003). Also,
the consumption of RS results in significantly higher concentrations of plasma peptide YY
(PYY) and glucagon-like peptide -1 (GLP-1) (Keenan et al, 2006; Zhou et al, 2006; Zhou et al.,
2008), which are satiety hormones released by the gut in response to nutrients. Both are
candidates for anti-obesity treatment (Murphy, Dhillo and Bloom, 2006; Young, 2006) because
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they reduce food intake and body weight when administered to humans and animals (Neary et al,
2005; Drucker, 2006).
Fructans are another type of fermentable fiber that occur naturally in a variety of plant
species (Van Loo et al, 1995). These fibers are fructose polymers whose β bonds make them
resistant to enzymatic digestion; ergo, they have a reduced caloric value, lead to fermentation
and increased concentrations of SCFAs in the colon, and stimulate the growth of beneficial
bacteria

(Niness,

1999).

Inulin

and

its

hydrolysis

product,

oligofructose

(a.k.a.

fructooligosaccharides [FOS]), are two well-known members of this group. Due to its longer
chain length, inulin is less soluble than oligofructose, allowing it to form microcrystals that
imitate a fat-like mouthfeel in food products. Oligofructose has a sweet, satisfying flavor and has
been be used to replace sugar in many low-calorie and low-sugar foodstuffs.
While there is no single, overriding cause of obesity, the elevated fat and sugar content of
modern Western diets is thought to be one of the main culprits, along with a sedentary lifestyle,
increased food availability and portion size, and chronic stress (Hill and Peters, 1998). Fat
contains more energy per gram than other nutrients, with high-fat (HF) foods having a higher
energy density than low-fat (LF) foods. Since humans tend to consume a relatively constant
weight of food, regardless of the fat content of the meal, diets that contain more HF foods have a
greater energy density than those that do not. This, together with the increased palatability of HF
foods, could lead to increased consumption and weight gain over time (Rolls, 2000; Drenowski,
1998; Rolls and Bell, 1999; Warwick et al, 2000).
Our lab is building a body of evidence supporting the idea that HF diets interfere with the
process of fermentation (Badkoobeh et al, 2010; Goldsmith et al, 2010; Senevirathne et al, 2009),
which could also help explain the effects of HF diets in increasing the incidence of obesity. In
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previous studies, ingestion of RS in LF diets resulted in decreased cecal pH from 8 to about 6,
indicating robust fermentation. However, in some preliminary studies, this effect of fermentation
was not seen when rodents were fed a HF diet. The amount of RS reaching the cecum was
greatly reduced with the HF diet. It appeared to have been digested during a potentially
lengthened transit time through the GI tract. In a separate study, we noticed that the numbers of
cecal bacteria that ferment RS were also reduced as well (Senevirathne et al, 2009). Moreover,
no significant loss of body fat was observed. It would behoove the scientific community to
investigate: (a) through what mechanism or mechanisms dietary fat might interfere with the
fermentation of dietary fiber, and (b) does dietary fat affect the fermentation of all fermentable
fibers equally regardless of theoretical digestibility (RS) or indigestibility (fructan).
Objective
The purpose of this study is to compare the effects of different types and combinations of
fermentable fibers on fermentation and body fat loss. Therefore, the goal is to determine which
types and/or combinations of prebiotics are better at enhancing fermentation than others in obese
animals fed a HF diet.
Hypothesis
A HF diet will interfere with the fermentation of dietary RS, but not dietary fructans. This
will be demonstrated by a decrease in percent total abdominal fat, a decrease in the pH of cecal
contents, increased full and empty cecal weights, increased serum PYY and GLP-1
concentrations, and an increased disemboweled body weight (DBW) in subjects fed fructans, but
not RS, in conjunction with a HF diet.
The reasoning behind this conclusion is that a HF diet increases transit time through the
gastrointestinal (GI) tract, and this may give α-amylase more time to digest the resistant starch. If
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this hypothesis is correct, then there should be less carbohydrate substrates available for
fermentation in the colon (Saunders and Sillery, 1988). We expect dietary fructans to reach the
cecum and be fermented regardless of the rate of intestinal transit, because fructans contain β
bonds, which are not broken down by human digestive enzymes. Ergo, fructans should not be
affected by the increase in transit time associated with the consumption of dietary fat.
Assumptions and Limitations
Although mice possess similar digestive physiology to that of humans, the results from
this study do not apply directly to humans. Researchers that work with murine models function
under the assumption that the blood and tissue samples collected from mice are representative of
human subjects. Morphological and behavioral differences between mice and humans include,
but are not limited to: coprophagia; possessing a much larger, more well-defined cecum;
possessing a diffuse, glandular pancreas that consists of many white nodules embedded within
the mesentery (Olds and Olds, 1979); and have a greater metabolic body size than humans,
which necessitates higher doses of prebiotics than would be easily tolerated by humans.
Nevertheless, mice and rats display similar phenotypical responses to bioactive dietary
compounds such as fermentable fibers. Also, they enable us to take samples and measurements
that would be too difficult in humans. Ergo, rodents are considered one of the best available
models of human digestive mechanisms.
It is impossible to balance energy and total (fermentable and non-fermentable) fiber
between diets simultaneously, since non-fermentable fiber is used to dilute the energy of the
control diet to the same level as the prebiotic diets. The addition of Hi-Maize® to the diet as the
source of RS2 adds energy to the diet at 2.8 kcal/g as well as total fiber as both fermentable and
non-fermentable. The latter occurs at the levels of RS added to the rodent diets. On the other
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hand, the purified cellulose used as the source of non-fermentable fiber in the control diet does
not provide any energy to the diet. Therefore, the RS diet has greater total fiber than the control
diet. This difference in total fiber content could be considered a confounding factor in this study.
However, by balancing for non-fermentable fiber, instead of total fiber, we are able to discern
which effects are occurring due to fermentation and independent of energy dilution.
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CHAPTER 2: REVIEW OF LITERATURE
(Re)Defining Fiber
A renewed interest in the relationship between colonic function, fiber, and health
emerged in the latter half of the twentieth century thanks to the “dietary fiber hypothesis” of
Burkitt and Trowell (1975), which blamed many of the so-called “diseases of civilization” (i.e.
cardiovascular disease [CVD], diabetes, obesity, constipation, diverticular disease, hemorrhoids,
colon cancer, etc.) on the consumption of refined carbohydrates and/or the lack of fiber-rich
foods in the diet. This theory was corroborated by several other prominent nutritionists of the
time, including, but not limited to, T.L. Cleave, N.S. Painter, A.R.P. Walker, and D. Kritchevsky
(Eastwood and Kritchevsky, 2005). This burgeoning interest in fiber and the beneficial effects of
its consumption resulted in a veritable battle to characterize it. As a result, the definition of fiber
has changed dramatically over the past half century, and has resulted in many slightly different
and, occasionally, conflicting descriptions worldwide.
Originally, the term “dietary fiber” strictly meant those portion(s) of plants foods that
were indigestible to human enzymes. These fibers were synonymous with “unavailable
carbohydrates” (Southgate, 1969) and included structural plant polysaccharides (e.g. cellulose,
hemicellulose, and pectin) and lignin, an associated polyphenol propane polymer. This was
opposed to “available carbohydrates,” which consisted primarily of starches that could be
digested and absorbed in the small intestine. These fibers were then subdivided into two main
categories: soluble fiber, which dissolves in water, and insoluble fiber, which does not. The
former gelatinizes during its journey through the intestine, thereby contributing bulk to stool,
while the latter alleviates constipation and encourages laxation. Soluble fiber is also, in part,
defined by its hypocholesterolemic effects, which are connected to its ability to bind bile salts.
This definition was inevitably found wanting, and has been the subject of much debate
7

and revision since then. This has been driven, at least in part, by the constant evolution of
analytical methods: The invention of new methods of extraction and isolation resulted in the
discovery of new fiber-like substances – that is, molecules that behave like traditional fiber
insomuch as they are not digestible and provide some benefit to human health – which
necessitated an expansion in the definition of fiber. For example, since 1987, the United States
Food and Drug Administration (FDA) has used a strictly analytical method to define fiber: Only
those materials isolated by the enzymatic-gravimetric process known as AOAC method 985.29,
which was developed by Prosky et al in 1985, are counted as dietary fiber on nutrition labels. In
1995, the World Health Organization (WHO) developed a similar definition, which includes
AOAC method 985.29 and 991.43.
Most recently, in 2005, the Institute of Medicine expanded the definition of fiber to
include purified gums and pectic substances, oligosaccharides such as inulin and
fructooligosaccharides, and resistant starches, under a new heading labeled “functional fiber.”
This new classification of fiber of includes starch and non-starch polysaccharides (NSP) that
may or may not be naturally occurring; have been isolated and extracted from preexisting food
products; or were created by some other chemical or enzymatic means. The Institute of Medicine
also suggested phasing out the terms “soluble” and “insoluble” in favor of others that provide a
better description of a given fiber’s physiological properties, such as viscosity and
fermentability.
The National Academy of Sciences recommends that men and women consume 38 and
25 grams of total fiber per day, respectively. However, the recommendation does not distinguish
between dietary and functional fibers, or between fermentable and non-fermentable fibers. The
effects of fermentable fibers on gut health have been a source of great interest in recent years due

8

to their numerous health benefits, especially in regards to weight management. These effects
include, but are not limited to, increased satiety, reduced body weight and body fat, protection
from colorectal cancer, and reduced postprandial glycemia and insulinemia (Slavin, 2005).
Fermentation and SCFAs
Our digestive system consists of not one, but two distinct processes. The first is digestion
by the human body, which begins with maceration in the mouth and continues with the secretion
of various enzymes and the absorption of breakdown products in the stomach and small intestine,
respectively. When carbohydrates or other non-starch polysaccharides (NSP) bypass this first
form of digestion, they may be fermented, or metabolized, by the resident bacteria of the large
intestine for energy. These bacteria include over 400 different species and exist in a
concentration of approximately 1011 organisms per gram of luminal contents (Savage, 1977).
They possess the glycoside hydrolases and polysaccharide lyases necessary for breakdown of
complex polysaccharides that are lacking in their human hosts’ small intestines (Stevens and
Hume, 2004).
The byproducts of this secondary digestion reaction by bacteria are short chain fatty acids
(SCFAs), lactate, hydrogen gas, carbon dioxide, and methane in addition to bacterial biomass
(Topping and Clifton, 2001). Acetate, propionate, and butyrate are the major SCFAs produced,
but others, such as isobutyrate, isovalerate, and valerate, are produced in smaller amounts.
SCFAs are important anions in the colonic lumen, because they increase colonic blood flow,
stimulate sodium and fluid absorption, prevent the growth and development of aberrant cells, and
have a proliferative effect on colonocytes, resulting in a thicker, healthier gut mucosa (Soergel,
1994; Scheppach, 1994). SCFA levels are highest in the proximal colon, where the concentration
of nondigestible carbohydrates is the greatest and the rate of fermentation is the highest. The
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lowest levels of SCFAs are found in the distal colon, since the majority of fermentable substrates
in fecal matter are fermented and absorbed in the proximal and transverse colon. SCFAs generate
approximately 1-2 kcal/g (Slavin et al, 2005) and are the primary energy source for colonocytes,
with butyrate being the preferred fuel type. Butyrate has been thought to be particularly
important for gut health, especially in the prevention of cancer. The mechanism is believed to
involve regulating cell growth and differentiation and encouraging apoptosis when necessary.
This has been determined in both in vitro (Whitehead et al, 1986) and in vivo (McIntyre et al,
1993) studies.
Many of the positive health effects attributed to increased levels of SCFAs and reduced
intestinal pH are linked to: stimulation and/or improved maintenance of muscosal and gutassociated lymphoid tissue (GALT); increased growth and activity of beneficial microorganisms
in the gut; and prevention of colonization and proliferation of potentially pathogenic bacteria
(Anderson et al, 2009). Buddington, Buddington, and Sunvold (1999) showed that adult dogs
consuming fermentable fibers had longer small intestines with a thicker mucosa and more
surface area – resulting in a greater capacity for nutrient absorption – than those supplemented
with non-fermentable fibers. In turn, Buddington and Weiher (1999) demonstrated that
fermentable fibers are useful dietary management tools when recovering from diarrhea,
especially when used in conjunction with oral rehydration/electrolyte solutions. Similar results,
i.e. the occurrence of thicker, stronger mucosa, were documented by our lab in regards to the
large intestine of rats fed RS (unpublished data). Neonatal pigs whose diets were supplemented
with fermentable fibers showed reduced recovery time and improved symptoms following
infection by Salmonella typhimurium, as measured by stool consistency and level of physical
activity (Correa-Matos et al, 2003). Enteral formulas supplemented with fermentable or non-
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fermentable fibers were also compared in infant pigs: the fermentable fibers were better at
maintaining and improving migration of small intestinal lymphocytes and neutrophils following
infection with the same pathogen (Milo et al, 2004). Similarly, supplementing total parenteral
nutrition with SCFAs results in increased natural killer cell activity in rats (Pratt et al, 1996).
Several other rat studies have shown that the inclusion of dietary fiber significantly decreases the
rate of bacterial translocation across the intestinal mucosal barrier (Spaeth et al, 1990; Schley
and Field, 2002).
Resistant Starch
Starch is a white, tasteless carbohydrate (C6H10O5)n that occurs, primarily, in the seeds
and tubers of plants. It provides plant life with an economical means of storing glucose in an
insoluble and tightly packed manner (Imberty et al, 1991). Structurally, starch comes in two
main forms: amylose – a linear, chainlike molecule consisting of α(1-4) bonds; and amylopectin
– a larger, branched polymer that contains both α(1-4) and α(1-6) glycosidic linkages.
Amylopectin is the most abundant polymer in starch, while the amount of amylose varies
between 15-20%, depending on the plant species from which the starch comes.
Starch is largely digestible by α-amylase, glucoamylase, and sucrose-isomaltase in the
small intestine (Nugent, 2005). However, RS is able to resist digestion by mammalian enzymes
in the small intestine and pass into the large intestine, where it is fermented by colonic
microflora. The fermentation of RS results in the same byproducts as the fermentation of fiber,
with the exception of the ratios of SCFAs produced: RS generates more butyrate and less acetate
than fiber (Nugent, 2005). RS was discovered in 1982 by Englyst and his colleagues when they
figured out that certain processed foods, such as white bread and cooked and cooled potatoes,
had greater NSP values than the equivalent raw products (Englyst, Wiggins, and Cummings,
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1982). As it turned out, this excess “fiber” was really starch that failed to be hydrolyzed into
glucose by digestive enzymes.
There are four major types of RS, which are defined based on the cause of resistance
(Table 1) (Topping, Fukushima, and Bird, 2003). RS1 escapes digestion because it is in a
physically protected form, i.e. embedded in a matrix that renders it inaccessible to digestive
enzymes. This type of RS is found in unprocessed whole grains, seeds, and legumes. Actions that
reduce particle size, such as mastication, milling, or grinding, generally reduce the amount of
RS1 present in a given food. RS2 exists in a physically dense form known as a starch granule,
which is composed solely of amylose molecules and can be tightly packed and folded into the
aforementioned shape, making it harder for digestive enzymes to gain access to its terminal
glucose units. It is commonly found in raw potatoes and unripe bananas. RS3, also known as
retrograded starch, describes non-granular starch that becomes resistant only after it has been
cooked and then cooled. This gelatinized starch is common in bread products and cooled potato
salad. RS4 is resistant to digestion because its bonds have been chemically modified. That is,
new chemical bonds other than the α(1-4) and α(1-6) linkages traditionally found in starch are
added. Examples include etherized, esterified, and/or cross-linked starch molecules and fatty acid
attachments.
Table 1. Description and potential food sources of different RS types
Type of RS
RS1
RS2

Description
Physically inaccessible starches;
protected by food matrix
Raw granular starches

RS3

Retrograded starches

RS4

Chemically modified starches
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Food Sources
Whole or partially milled grain, rice,
seeds, legumes, and pasta
Raw potatoes, green bananas, high
amylose starches
Cooked and cooled potatoes, bread, and
cornflakes
Not naturally occurring; foods in which
modified starches have been used

Concerning microbial fermentation, RS has a prebiotic effect in the large intestine and leads to
increased SCFA production, which reduces cecal and fecal pH levels. Fermentation and the
liberation of SCFAs are associated with increased proglucagon – the precursor for GLP-1 – and
PYY gene expression (Keenan et al, 2006; Zhou et al. 2006,), especially in the cecum and
proximal colon, where the bulk of fermentation occurs and its SCFA byproducts are located.
Increases in plasma GLP-1 and PYY concentrations have also been documented (Keenan et al.
2006; Zhou et al., 2008; Shen et al, 2008). These outcomes could be beneficial in the control of
metabolic syndrome, diabetes, and, potentially, obesity.
GLP-1 and PYY are anorexic/satiety hormones secreted by the gut in response to the
presence of nutrients. PYY has been shown to reduce food intake and weight gain when infused
in human subjects as well as animal models (Batterham et al, 2002; Batterham et al, 2003).
Proglucagon is the precursor of several peptide hormones, including glucagon and GLP-1.
Proglucagon is destined to become GLP-1 if it is secreted by the L cells of the small intestine.
GLP-1 also reduces food intake and body weight in animals and humans (Neary, 2005; Drucker,
2006). These two hormones and others like them alter energy balance by sending signals from
the gut to the brain, thereby changing brain neuropeptide expression (Wren and Bloom, 2007).
Specifically, through activation of hypothalamic proopiomelanocortin (POMC) neurons, which
are associated with increased energy expenditure and could be, in part, responsible for the body
fat effect seen in RS-fed animals when compared to an energy-control (Keenan et al., 2006; Shen
et al, 2009; Zhou et al., 2009). Both have been proposed as potential anti-obesity/diabetes drugs.
RS has a smaller net metabolizable energy value than digestible starch; approximately
2.68 to 3.06 kcal per gram of RS rather than 4.00 kcal per gram of regular starch (Tulley et al,
2009). Adding RS to a diet dilutes the energy density of the diet, resulting in reduced caloric

13

intake as well as reduced postprandial glycemia and insulinemia (Brennan, 2005). Also, when
rodents were fed a diet that consisted of 25% RS2, they ended up with less body fat than rodents
eating the same number of calories of an isocaloric diet, but no RS (Keenan et al, 2006; Shen et
al, 2008; Zhou et al, 2009). This statistic does more than highlight the potential weight
capabilities of RS replacement. It shows that the aforementioned reductions in adiposity go
beyond simple energy dilution, because they are compared to an energy control, whose energy
density has been diluted by the addition of cellulose. Other documented effects of RS
replacement are greater full and empty cecal weights, lower pH value of cecal contents (which is
beneficial for gut health), and increased plasma GLP-1 and PYY concentrations. All of which are
associated with, and may be, the result of the fermentation of the RS that has reached the colon.
However, these effects, as well as the reduction in percent total abdominal fat, are attenuated
when the diet in question has a HF (20%) content as opposed to a LF (7%) content (Zhou et al,
2009) . Ostensibly, this occurs because RS is not reaching the cecum (unpublished data),
potentially due to increased transit time resulting from the greater fat content of the diet
(Saunders and Sillery, 1988). According to Kendall et al (2004), RS doses of 20-30 g/day are
needed to observe physiological effects in humans. This level of consumption is 3-4 times higher
than actual levels of RS consumption in the United States, which is estimated to be 3-8 g/day
(Murphy et al, 2008).
Fructans
Fructan is the name given to members of a family of oligo- and polyfructoses composed
primarily of β(2-1) and/or β(2-6) linkages between several to many fructose molecules, with or
without a terminal glucose molecule. These bonds make fructans indigestible to mammalian
enzymes and, therefore, fermentable. After starch, fructans are the most abundant non-structural
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polysaccharide found in nature. Americans consume an approximately 1–4 g of inulin and
oligofructose per day, while Europeans average 3–10 g/d (Van Loo et al, 1995). Intake varies
according to geographic region and season as well as race and socioeconomic status (Moshfegh
et al, 1999). One of the most common structural forms of fructans is the polymer inulin, which
can be hydrolyzed into oligomers of fructooligosaccharides (FOS). Both contribute 1.5 kcal/g
and are abundant in a variety of plants including, but not limited to, wheat, onions, Jerusalem
artichokes, jicama, green beans, and leeks (Roberfoid, 2007). Studies have shown that the
ingestion and subsequent fermentation of fructans provide many of the same health benefits as
other fibers, such as aiding in colon function by increasing stool frequency and weight (Cani and
Neyrinck et al, 2005; Roberfoid, 2005). For all of these reasons, fructans can be classified as a
part of the dietary fiber complex (Roberfoid, 1993). However, since most commercially available
inulin and oligofructose is either synthesized from precursors or extracted from fructancontaining plants, they can also be sorted into the functional fiber category.
The number of publications proclaiming the health benefits of inulin and oligofructose is
impressive. Since fructans are not broken down by mammalian enzymes, they have no real
influence on blood glucose or insulin levels after ingestion. This makes them useful ingredients
in processed foods geared towards diabetics. The consumption of fructans has been linked to
improved lipid metabolism in humans, resulting in reduced serum triglyceride and LDL
cholesterol levels in hyperlipidemic individuals (Davidson and Maki, 1999). The effects of
fructans on lipid metabolism have consequences on the development of atherosclerosis as well.
ApoE-deficient mice fed inulin at 10% w/w developed significantly less aortic plaque than
controls (Rault-Nania et al, 2006).
Both inulin and oligofructose are well-known as stimulators of the growth and metabolic
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activity of a select number of beneficial bacterial species, including lactic acid-producing
Bifidobacterium spp and Lactobacillus spp (Gibson and Roberfoid, 1995). Consumption of
fructans is tantamount to feeding these valuable bacterial species; helping them to outcompete
other, potentially pathogenic organisms such as certain Clostridia spp, Candida albicans,
Salmonella, or Listeria (Buddington, Donahoo, and Buddington, 2002; Gibson and Roberfoid,
1995; Roberfoid, 2007; Wand and Gibson, 1993).
Like RS, fructans helps modulate food intake and satiety through the agency of its SCFA
byproducts. The consumption of inulin-type fructans is associated with increased portal serum
GLP-1 and colonic proglucagon gene expression, increased serum glucose-dependent
insulinotrophic polypeptide (GIP), and decreased serum ghrelin in both rats and mice (Cani et al,
2004; Cani et al, 2005). GLP-1 is of particular importance, since treatment with a GLP-1
receptor antagonist abolishes improvements in glucose tolerance and insulin sensitivity normally
associated with the consumption of oligofructose (Cani et al, 2006).
High Fat Diets and Gut Microbiota
The obesity epidemic is the result of interplay between a myriad of biological,
psychological, and environmental factors. Even so, much of the credit is given to the HF content
of the modern Western diet, in part because fat has a greater energy density than either protein or
carbohydrate (9 kcal/g versus 4 kcal/g), and is considered more palatable, which can easily lead
to overconsumption of calories (Rolls, 2000; Drenowski, 1998; Rolls and Bell, 1999; Warwick et
al, 2000). What's more, eating foods that contain large amounts of dietary fat is not the same
thing as eating a HF diet. The consumption of dietary fat results in the inhibition of gastric
emptying; stimulation and subsequent release of various satiety hormones, including PYY and
GLP-1; and reduction of energy intake at successive meals. However, many animal and some
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human studies have shown that chronic consumption of foods with high dietary fat content can
alter the normal effects of fat on gastric emptying and intestinal transit as well as the secretion
and action of GI peptides (Little, Horowitz and Fienle-Bisset, 2007). Chronically HF diets have
also been known to affect the gut microbiota which, in turn, affects the fermentation of fiber and
the health of the host (Cani et al, 2007; Senevirathne et al, 2009).
The microbiota constitutes a metabolic “organ” in so much as it performs functions that
we have not had to evolve on our own. These functions include the ability to process otherwise
indigestible components of our diet. The result is an increased capacity for energy harvest.
Adult-germ free (GF) mice conventionalized with normal microbiota harvested from
conventionally raised animals results in a 60% increase in body fat content despite decreased
food intake (Bäckhed et al, 2004). It is not just the presence of the microbes in the gut that
affects health and adiposity, but the composition of the bacterial population as well. According to
Lay et al (2005), in healthy adults, 80% of known fecal microbiota can be classified into 3
dominant phyla: Bacteroidetes, Firmicutes, and Actinobacteria. In general, the Firmicutes to
Bacteroidetes ratio is considered to be extremely relevant in human gut microbiota composition.
The microbiota in obese subjects shows an elevated proportion of Firmicutes and a reduced
population of Bacteroides. Conversely, a decreased Firmicutes to Bacteroidetes ratio has been
directly related to weight loss (Ley et al, 2006). This ratio is not static. It is greatly affected by
the composition of the host’s diet.
Our lab has had some difficulty preserving the fermentation of RS in rodents, especially
mice, made obese by a HF diet. The stereotypical outcomes associated with RS consumption –
i.e. increased cecal size, reduced cecal pH, and reduced adiposity – are lost in mice made obese
on a HF diet (Zhou et al, 2009). Humans and animals made obese and/or diabetic through HF-
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feeding also exhibit increased metabolic endotoxemia – as measured by increased plasma
concentrations of lipopolysaccharide (LPS), an inflammatory compound and major component
of the outer membrane of Gram (-) bacteria – in addition to adipose tissue inflammation and
metabolic disorder (Amar et al, 2008; Cani et al, 2008). HF diets are also known to alter the
Gram (-) to Gram (+) ratio, reducing the concentrations of important Gram (+) bacteria, such as
Bifidobacteria spp, which help reduce endotoxemia and improve mucosal function (Cani et al,
2007); ostensibly, through its ability to ferment fiber and stimulate the host’s immune system. As
a doctoral student in our lab, Dr. Reshani Senevirathne determined that the number of colony
forming units (CFU) of Bifidobacterium spp., Lactobacillus spp., and beneficial Clostridia spp.
isolated from cecal contents of C57Bl/6J mice fed RS, were greatly reduced in a HF (41% total
energy), but not low (18%) or medium fat diets (28%) (Senevirathne et al, 2009).
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CHAPTER 3: MATERIALS AND METHODS
Animals, Housing, and Diets
One hundred male C57BL/6 mice (JAX® Mice and Services, Ben Harbor, Maine), aged
7-8 weeks, were housed in groups of 3 or 4 in shoebox cages in a climate-controlled environment
(22 ± 2°C, 65-67% humidity) with a 12:12 h light-dark cycle illuminated at 7 AM. For three
weeks prior to treatment, subjects were fed a high-fat, high-energy diet (D12331, Research Diets,
New Brunswick, NJ) in order to induce weight gain, as well as to become acclimated to the
powdered diet and new environment.
Next, the animals were stratified according to weight, and assigned to one of ten energybalanced (4.0 ± 0.1 kcal/g) diets whose general percent compositions by weight (g/kg) are shown
in Table 2. (Note that the study was analyzed as a completely randomized design because body
weight is a dependent variable and randomization without regard to body weight would bias the
analyses).

A complete diet table can be found in Appendix C: Diet Table and Mixing

Instructions.
Table 2. General percent compositions by weight (g/100 g) of experimental diets

Protein
Carbs
Fat
RS
Fructan

C
(n=20)

R
(n=10)

N
(n=10)

F
(n=10)

I
(n=10)

F/I
(n=10)

R/F
(n=10)

R/I
(n=10)

R/N
(n=10)

14%

14%

14%

14%

14%

14%

14%

14%

14%

43%

55%

55%

45%

45%

45%

55%

55%

55%

20%

20%

20%

20%

20%

20%

20%

20%

20%

-

29%

29%

-

-

-

23%

23%

29%

-

-

-

10%

10%

10%

10%

10%

10%
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Originally, we planned on having two levels of FOS consumption: 10% by weight to match the
fermentable fiber levels popular in the scientific literature, and 30% by weight to match the
levels of RS that our lab uses for our RS diets. We also created two different control diets in
order to ensure that we did not make an unfair comparison between diet groups containing two
drastically different levels of fermentable fiber. Since RS is not as readily fermentable as
fructans, more of it is required in order to achieve beneficial health effects. Unfortunately, we
were unable to get the higher concentration of fructans into the diets: the mixture became
discolored and started to clump in a very unappetizing manner. In the end, we determined that
the two control diets were similar enough in general composition, nonfermentable fiber content,
and energy density to be pooled together for analyses, resulting in one large control group (See
Appendix B).
The combined control diets (C) were compared to diets containing four different
prebiotics: Hi-Maize® (R), Novelose® (N), (National Starch Food Innovation, Bridgewater, NJ)
Nutraflora® fructooligo-saccharide (F), (GTC Nutrition and Corn Products International,
Westchester, IL) and Orafti HP gel® (I), (a gift from Dr. Kai Aryana, LSU, Dairy Science)
which were fed individually and in certain combinations (F/I, R/F, R/I, and R/N). Water and
assigned semipurified powder diet were available ad libitum throughout the experiment. The
experimental protocol was approved by the Louisiana State University Institutional Animal Care
and Use Committee (IACUC #06100), which can be found in full in Appendix A.
Methods and Measurements
Due to the large number of subjects, the sacrifice took place over a three-day period. At
sacrifice, mice were weighed prior to exsanguination via cardiac puncture under isoflurane
anesthesia. After all of the blood was withdrawn, the chest was opened and the heart was
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removed to assure death prior to dissection. The blood was collected in EDTA tubes and
centrifuged at 4000g for 20 minutes in order to extract serum, which was used to determine
plasma PYY and total GLP-1 concentrations using a radioimmunoassay kit from Millipore (St.
Louis, MO).
Epididymal, perirenal, and retroperitoneal fat pads from the abdominal cavity were
dissected, and their combined weight was counted as total abdominal fat. Full and empty cecal
weights were recorded, and the weight of the cecal contents was calculated as full cecal weight
minus empty cecal weight. Also, disemboweled body weight (DBW) was determined by
subtracting the weight of the full GI tract (rats not fasted prior to sacrifice), which included the
stomach as well as the small and large intestines, from the weight of the animal from which it
came.
The cecal contents were stored in separate 1.5mL microcentrifuge tubes and preserved in
liquid nitrogen. Later the samples were transferred to a deep freeze (-80°C) for long term
storage. The pH of the cecal contents was determined by using a combination electrode in
thawed cecal contents that had been homogenized in distilled water at a ratio of 0.5 g sample to 5
ml water. Next, the samples were acidified with 1 ml of a 25% (w/w) solution of metaphosphoric acid, which contained 2g/l of 2-ethyl-butyric acid as an internal standard for the
SCFA contents. The solids in the homogenates were separated by centrifugation, and the effluent
was analyzed using gas-liquid chromatography.
Statistical Analysis
Data was analyzed using PASW® (formerly SPSS) Statistics GradPack 18. A one-way
ANOVA followed by LSD post hoc mean comparison test was performed for all measurements.
Results were considered significant at p<0.05. Values are expressed as means ± SE.

21

CHAPTER 4: RESULTS
All prebiotic groups had significantly greater full and empty cecal weights than the control
group (p<0.000). The R group consistently displayed the smallest increases among the treatment

Weight, grams

groups (Fig 1 and 2).
0.90
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0.70
0.60
0.50
0.40
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0.10

*
*

*

*

I

F/I

*
*

*

*

C

R

N

F

R/F

R/I

R/N

*

*

*

R/F

R/I

R/N

Diet

Fig 1. Full Cecal Weight.
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*
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*
0.20

*

*

F

I

*
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0.05
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C

R

N
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Diet

Fig 2. Empty Cecal Weight.
Our lab considers fermentation to have occurred when the pH value of the cecal contents is
significantly reduced when compared to the control. This occurred with all fructan (F, I, and F/I)
and combination (R/F, R/I, R/N) groups. The R and N groups individually failed to reduce the
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pH of the cecal contents, despite the aforementioned increases in full and empty cecal weights.

pH

In fact, the N group exhibited a pH value that was numerically greater than the control (Fig 3).
9
8.5
8
7.5
7
6.5
6
5.5
5

*

C

R

N

F

*

*

*

*

*

I

F/I

R/F

R/I

R/N

Diet

Fig 3. pH of Cecal Contents.
The concentration of SCFAs (acetate, propionate and butyrate) in the cecal contents (mM/g
wet weight) varied greatly between groups, and depicted no correlated increases in significant
decreases in pH levels. There was no significant difference between the C, R, N, and I groups. F,
R/F, R/I, and R/N were significantly greater than both the C and R groups, and F/I was
significantly greater than R, but not C (Fig 4 and Fig 5; a = significantly different from C; b =
a,b

SCFA, mmole/g

100

a,b

a,b

80
b

60

a,b

40
20
0
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N

F

I

F/I

R/F
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Fig 4. Total SCFA Concentration, mmole/g.

23

R/N

significantly different from R; a,b = significantly different from both C and R).
a,b
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R/F
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Fig 5. Total SCFA Concentration, mmole.
There were no significant differences in percent total abdominal fat (total abdominal
fat/DBW) between the groups (p>0.056; Fig 6). An increase in DBW (p<0.000; Fig 7) was
observed in subjects that consumed FOS, either alone or in combination with other prebiotics,
but there was no concurrent increase in the DBW to fat ratio (p>0.566).
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Fat, g

4.00
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Fig 6. Abdominal Fat at Sacrifice.
We were unable to obtain data on the serum concentrations for PYY and GLP-1, because
the antibody in our RIA kits was defective and we did not have enough serum sample to run the
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assay a second time.
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Fig 7. Disemboweled Body Weight.
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CHAPTER 5: DISCUSSION
The purpose of this study was to determine which fermentable fibers, if any, would be
fermented better by the intestinal microflora of mice fed a HF diet. We hoped that, by
experimenting with different types and combinations of fermentable fibers, that we could (a)
determine whether or not a HF diet interferes with the fermentation of all fermentable fibers
equally; and (b) determine whether or not we could preserve the fermentation of RS and salvage
the fibers’ ability to reduce body fat on a HF diet. We assumed that the cause of the diminutive
fermentation seen in animals on HF diets was due to RS not reaching the cecum (unpublished
data), because the consumption of fat is known to slow intestinal transit (Saunders and Sillery,
1988). Presumably, digestive enzymes would have more time to degrade the RS, resulting in less
RS making it to the cecum to be fermented. We also assumed that, because fructans were
completely immune to digestion in the small intestine, that they would not be affected by
changes in intestinal transit. Diets containing fructans, or a combination of fructans and RS,
would result in greater fermentation than diets that just had RS, and as a result of this
fermentation there would be a decrease in body fat. We may have been mistaken.
Body Fat and DBW
Unfortunately, we did not see an effect of any treatments on reducing body fat as has
been observed in our studies with low fat diet consumption with RS (Keenan et al., 2006, Shen et
al., 2009; Zhou et al. 2009). Differences in percent total abdominal fat levels (abdominal fat
pads) at sacrifice were statistically not significant. There were promising, significant increases
in the DBW of animals fed diets containing FOS, but there was no parallel decrease in the
abdominal fat pads/DBW ratio. Therefore, we cannot be certain that those subjects
predominantly gained lean muscle over fat since total body protein was not measured in this
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study. Our lab normally uses DBW and the abdominal fat pads/DBW ratio, because we do not
fast animals prior to sacrifice. Fasting would interfere with the observation of fermentation
effects (unpublished data) and hormone production (Roy et al. 2003). Additionally, rodents fed
RS diets have greater GI tract contents than control rodents due to fermentation (Keenan et al.
2006). Thus, DBW is used in order to prevent bias of the total abdominal fat/body weight ratio
in favor of the RS fed rodents. An equal amount of total abdominal fat for RS and control would
end up with a lower total abdominal fat/DBW ratio if body weights with the contents of the GI
tract are used. However, the use of DBW may actually favor the control rodents, since the GI
tract is a legitimate component of the animal’s lean tissue. Future studies will use the DBW plus
the empty GI tract weight in order to avoid that particular bias. The latter may be the superior
factor for measurements of adiposity when studying animals consuming fermentable fibers. We
expected to see a lack of favorable changes in adiposity with obese, RS-fed animals, because of
previous results obtained from experiments on genetic models of obesity (Zhou et al, 2009).
What we did not expect to see was the same outcome for animals fed inulin or FOS. This was
surprising for a number of reasons: (1) With the exception of the R group, the prebiotic groups
had increased both full and empty cecal weights compared to control, which is typically
indicative of robust fermentation reactions; and (2) according to the scientific literature, we
should have seen reductions in body fat in animals fed fructans with significant, positive changes
in cecal weight. Collaborating scientists, Dr. Patrice Cani, Dr. Nathalie Delzenne, Dr. Catherine
Daubioul, and Dr. Jacques Amar, have consistently documented body fat and body weight loss in
various animal models (i.e. rats on normal and HF diets, obese and diabetic rats) supplemented
with 10% inulin or oligofructose (Cani and Neyrinck et al, 2005; Cani and Daubioul et al, 2005;
Daubiol et al, 2000; Daubioul et al, 2002). These changes in adiposity were often accompanied

27

by reduced postprandial serum triglyceride and cholesterol levels.
The results of Daubioul et al (2002) were particularly interesting, since fatty Zucker
(fa/fa) rats are decent corollaries to our diet-induced obese mice as both are obese models.
However, Zucker rats are a genetic model of obesity that may have a microflora that can robustly
ferment fructans. Our diet-induced obese mice were lean before feeding a Western diet and may
have had their ability to robustly ferment fructans reduced with the Western diet used to induce
obesity in the run-up to the current study. Thus, feeding a HF diet prior to feeding a fermentable
fiber may produce different effects than feeding the high fat in conjunction with the inclusion of
a fermentable fiber in the diet. It is also possible that rats are better able to compensate for the
effects of prior obesity in regards to fermentation. If that is the case, it might behoove our lab to
consider using rats exclusively in future studies that include both HF diets and fermentable
fibers. Another added benefit of using rats is directly related to their greater size. There is
significantly more blood and tissue in rats compared to mice, both of which are easier to collect
in the former compared to the latter. Also, there would be a decreased likelihood of missing or
altering the statistical significance of data points by accident through human error at sacrifice.
The work of Daubioul et al (2002) was also the only one of the aforementioned studies
that used animals that were already obese (fatty [fa/fa] Zucker rats) prior to supplementation with
fructans, as was done for the current study. In the current study, it is also possible that the
microbial composition of the animals’ GI tract was significantly and negatively altered during
the initial HF feeding referred to above and described in the Materials and Methods section.
Without the proper concentration and/or composition of bacteria in the colon, the fructans and
other fermentable fibers cannot be robustly broken down and thus cannot contribute to the body
fat effect normally characteristic of its consumption. The Zucker rats may not have had similar
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changes in the gut microflora as in the current study.
pH and SCFAs
The amount of fermentation in the cecum as determined by pH levels alone was possibly
reduced as compared to a previous study (Keenan et al. 2006), which possibly explains why the
animal subjects did not lose significant amounts of body fat. Significant decreases in pH levels
were documented for all groups ingesting fructans individually and in combination with other
fibers. The group fed the combination of RS2 and RS3, R/N, also had a significantly lower cecal
content pH, but neither type of RS affected pH when fed individually. Additionally, the N group
had increased full and empty cecal weights without a corresponding reduction in the pH of cecal
contents. This result is an anomaly. It is possible that this type of RS is able to affect cecal size
by some means other than fermentation, perhaps through a bulking effect caused by the
simultaneous stretching and growth of the organ itself, but the this is an unknown at this time.
As previously stated, the amount of fermentation was less than expected. In this study,
most of the groups that had significant changes in pH had pH values between 7.0 and 7.5, but in
a previous study we observed pH values between 6.5 and 7.0. Only the pH of cecal contents for
the F group fit within the range of previously published data.

These possibly moderate

reductions in pH were accompanied by reduced production of combined acetate, propionate and
butyrate concentrations overall. Once again, the R and N groups were ineffective at reducing the
pH of the cecal contents compared to control but, groups that contained FOS or a combination of
fermentable fibers in their diets had statistically significant lower pH of cecal contents compared
to control. The amount of SCFAs measured for F, F/I, R/F, R/I, and R/N groups were greater
than the C and R groups, which were statistically identical.
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Gut Hormones
The lack of data regarding plasma concentrations of gut hormones is disappointing, to say
the least. If I had to speculate about what the results would have been, I would expect either no
significant changes or a slight trend towards increased plasma concentrations of PYY and GLP-1
in animals fed fructans. This would match the results we obtained for pH levels and total SCFA
concentrations of the cecal contents.
The central GLP-1 receptor system in the brain decreases fat storage by direct modulation
of lipid metabolism in lean, but not obese, animals. Diet-induced obese animals receiving an
intracerebroventricular infusion of GLP-1 fail to decrease lipid stores in white adipose tissue.
This suggests that obese animals become resistant to the actions of GLP-1 (Nogueiras et al,
2009). Diet-induced obese mice also develop hyperglycemia, hyperinsulinemia, hyperleptinemia,
and develop leptin resistance. Leptin stimulates the secretion of GLP-1. Obese animals,
including humans, develop concurrent resistances to both leptin and GLP-1, resulting in reduced
plasma GLP-1 levels overall (Anini et al, 2003). It is possible that leptin-resistance developed in
the mouse model used in this study. If this is true then fermentation could have been enough to
stimulate fat oxidation and weight loss, but was undermined but the resulting leptin resistance.
Obese animals do not appear to be resistant to the actions of PYY as they are with leptin and
GLP-1. Obese humans are able to respond to the effects of PYY, but possess lower endogenous
fasting and postprandial levels of PYY. It is possible that the reduced level of fermentation seen
in obese animals contributes to the pathophysiology of obesity by reducing plasma PYY
concentrations (Batterham et al, 2003).
Reflections
Reduced fermentation of RS, but not fructans, can be explained by the hypothesis present
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in my introduction. An alternative hypothesis, which was partially explained and supported in
the subsection “Body Fat and DBW”, could be that a HF diet reduces the concentration of
beneficial, fermentative bacteria in the colon, in which case we would expect to see little or no
fermentation of both types of fiber no matter what individual fibers or combination of fibers
were used . The intestinal microflora could have been changed in one of two ways: during the
initial high fat feeding, which made all of the mice overweight, or during the treatment, which
included a high fat diet. Most likely, this deleterious change would have occurred prior to
treatment, since HF-fed diabetic mice treated with oligofructose reduced body fat gain compared
to a HF-fed control (Cani et al, 2006). This wouldn’t be possible if the microflora had changed
during treatment. Based on Cani et al (2006), it would appear that the inclusion of fermentable
fibers in a HF diet might prevent the negative changes to the intestinal microflora normally
associated with fat-enriched diets.
Another possibility is that the fermentation of fructans was enough to induce changes in
gut hormones and adiposity, but the HF diet interferes with the body fat effect somewhere distal
to the gut. Likely sites of interference include; within the brain (Nogueiras et al, 2009),
specifically, within the arcuate nucleus of the hypothalamus, where gut hormones bind and affect
lipid metabolism directly; or at the level of gut hormones themselves (Batterham et al, 2003),
which would be mediated by interactions with other hormones such as leptin produced in white
adipose tissue.
A third alternative hypothesis is that the high energy density of the HF diets causes
decreased consumption of the powered diets. That is, the animals are not consuming enough
fiber because, volumetrically speaking, they don’t need to consume as much of the diet in order
to meet their caloric needs. However, without accurate data on food intake, I can neither confirm
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nor refute this hypothesis at this time.
Conclusion
The term "RS" refers to starch that is not digested into glucose in the small intestine like
refined carbohydrates, such as starch in white bread and pasta, typically are digested. Because
RS withstands digestion in the small intestine, it travels on to the large intestine, where it
becomes food for the bacteria that reside there. This reaction is known as fermentation, and its
byproducts include increased concentrations of SCFAs and the proliferation of beneficial
bacteria. Both of which are thought to have beneficial effects on human health.
Our lab has difficulty documenting the fermentation of RS and the health benefits that
normally accompany its consumption in animals that are obese and/or consuming a chronically
HF diet. The purpose of this study was to determine whether or not this was true for all types and
combinations of fibers. We thought that, due to their chemical nature, fructans would be capable
of withstanding the increased transit time that accompanies the consumption of a HF diet. We
expected that the consumption of fructans or a combination of fructans and RS would result in
fermentation and body fat loss.
As it turns out, our hypothesis was only partially correct. Fermentation occurred with
individual fructans and with all combination groups, but there was no reduction in percent total
abdominal fat. The R and N groups were the least effective fermentable fibers out of all the
prebiotic treatments when included in a HF diet. Conversely, the F group and, to a lesser extent,
the I group, were the most fermentable fibers overall. Somehow, the consumption of Novelose®
resulted in increased full and empty cecal weights without a corresponding reduction in cecal pH
or increase total SCFA concentration. This is an anomaly and we have no plausible explanation
for this result.
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It is possible that a HF diet inhibits the growth of microbes that engage in fermentation,
thereby reducing fermentation in the gut and contributing to weight gain. This would suggest that
the health benefits of prebiotic ingestion may only be evident on a LF diet, or that prebiotics may
need to be consumed separately from HF foods. It is also possible that, while the level of
fermentation was seemingly reduced on the HF diet, it is still enough to elicit the characteristic
effects of increased fat oxidation and weight loss through increased gut hormone production. If
this is the case than the HF diet would have to act in a manner that is distal to the gut; potentially
by blocking the effects of gut hormones within the brain.
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APPENDIX: DIET TABLE AND MIXING INSTRUCTIONS

INGREDIENTS
k J/g

C1
k cal/g

gram

C2
kJ

366.90

gram

N
kJ

14.65

3.50

Hi-Maize

11.72

2.80

Novolose

11.72

2.80

6.28

1.50

Sucrose

16.75

4.00

100.00

1674.80

100.00

1674.80

100.00

Casein

14.99

3.58

140.00

2098.52

140.00

2098.52

140.00

125.00

0.00

145.00

0.00

Cellulose

5669.83

R
kJ

Amioca

Inulin / scFOS

386.90

gram

gram

F
kJ

gram

5376.74

kJ

296.90
511.90

4350.92

6001.31
511.90

6001.31
100.00

628.05

1674.80

100.00

1674.80

100.00

1674.80

2098.52

140.00

2098.52

140.00

2098.52

115.00

0.00

Oil

35.38

8.45

100.00

3538.02

100.00

3538.02

100.00

3538.02

100.00

3538.02

100.00

3538.02

Lard

36.85

8.80

100.00

3684.56

100.00

3684.56

100.00

3684.56

100.00

3684.56

100.00

3684.56

Mineral Mix

3.68

0.88

35.00

128.96

35.00

128.96

35.00

128.96

35.00

128.96

35.00

128.96

Vitamin Mix

16.20

3.87

10.00

162.04

10.00

162.04

10.00

162.04

10.00

162.04

10.00

162.04

1.30

0.00

1.30

0.00

1.30

0.00

1.30

0.00

1.30

0.00

1.80

30.15

1.80

30.15

1.80

30.15

1.80

30.15

1.80

30.15

1000.00

16986.87

1000.00

16693.78

1000.00

17318.35

1000.00

17318.35

1000.00

16296.01

Choline Chloride
L-Cysteine

16.75

4.00

Total
Total (kcal/g)

4057.05

3987.05

4136.22

4136.22

3892.05

4.06

3.99

4.14

4.14

3.89

% diet

INGREDIENTS
k J/g

I
k cal/g

gram

gram

4350.92

296.90

R/F
kJ

gram

R/I
kJ

gram

Amioca

14.65

3.50

Hi-Maize

11.72

2.80

256.00

3001.24

Novolose

11.72

2.80

255.90

3000.07

Inulin / scFOS

296.90

F/I
kJ

R/N
kJ

gram

kJ

4350.92
411.90

4828.95

411.90

4828.95

6.28

1.50

100.00

628.05

100.00

628.05

100.00

628.05

100.00

628.05

Sucrose

16.75

4.00

100.00

1674.80

100.00

1674.80

100.00

1674.80

100.00

1674.80

100.00

1674.80

Casein

14.99

3.58

140.00

2098.52

140.00

2098.52

140.00

2098.52

140.00

2098.52

140.00

2098.52

115.00

0.00

115.00

0.00

Cellulose
Oil

35.38

8.45

100.00

3538.02

100.00

3538.02

100.00

3538.02

100.00

3538.02

100.00

3538.02

Lard

36.85

8.80

100.00

3684.56

100.00

3684.56

100.00

3684.56

100.00

3684.56

100.00

3684.56

Mineral Mix

3.68

0.88

35.00

128.96

35.00

128.96

35.00

128.96

35.00

128.96

35.00

128.96

Vitamin Mix

16.20

3.87

10.00

162.04

10.00

162.04

10.00

162.04

10.00

162.04

10.00

162.04

1.30

0.00

1.30

0.00

1.30

0.00

1.30

0.00

1.30

0.00

1.80

30.15

1.80

30.15

1.80

30.15

1.80

30.15

1.80

30.15

1000.00

16296.01

1000.00

16296.01

1000.00

17318.35

1000.00

16774.04

1000.00

16774.04

Choline Chloride
L-Cysteine
Total
Total (kcal/g)
% diet

16.75

4.00

3892.05

3892.05

4136.22

4006.22

4006.22

3.89

3.89

4.14

4.01

4.01
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1. MACRO MIX
a. Weight each ingredient individually on balance
b. Add to larger mixing bowl in the following
order:
i. Sucrose
ii. Casein
iii. Starch
iv. Fiber
c. Stir evenly to distribute
d. Place in Hobart MFG commercial mixer and
process at low speed for 10 minutes
i. Scrape sides
ii. Repeat

f. Add micro mixture to macro mix in Hobart
MFG commercial mixer and process at low
speed for 10 minutes
i. Scrape sides
ii. Repeat
3. OIL MIX
a. Weight each ingredient individually in small
bowl on balance
i. Corn oil
ii. Lard
b. Place ingredients into medium-sized bowl
c. Using handheld mixer, process at low speed
until creamy

2. MICRO MIX
a. Weigh remaining dry ingredients individually
on balance
b. Add to smaller mixing bowl in the following
order:
i. Mineral Mix (AIN-93G)
ii. Vitamin Mix
iii. Choline Chloride
iv. L-Cysteine
c. Stir evenly to distribute
d. Mix desired food coloring into 1 cup distilled
water and add to dry ingredients
e. Using handheld mix, process at low speed for
10 minutes

4. FINAL MIXING
a. Add oil mixture to center of dry mixture in
Hobart MFG commercial mixer
b. Process at low speed for 10 minutes
i. Scrape sides
ii. Repeat twice
5. STORAGE
a. Place in gallon Ziplock bags
b. Mark container in the following manner:
Study ID / Diet Name / Date / Initials
Batch # / Date / Initials
c. Store in freezer

43

